14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
AXNX vs ATRC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, AtriCure, Inc. (ATRC) is the stronger overall head-to-head candidate over AXNX (AXNX) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AXNX carries a Unified Composite Score of 52.1/100 (HOLD) at $0.83 (N/M Forward P/E, N/A operating margin), whereas ATRC carries 53.7/100 (HOLD) at $55.39 (122.1x Forward P/E, 2.9% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs ATRC. Trailing 12-month operating profitability (AXNX N/A vs ATRC 2.9%) and valuation multiples (AXNX N/M vs ATRC 122.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Instruments & Supplies value chain with $2.8B market capitalization and 2.9% operating margin.
OpEx & R&D Reinvestment73.8% of Rev ($435M)
90D Engineering Disclosures0 Published
Investor FAQ AXNX vs ATRC Key Questions & Quantitative Answers
As of Nov 20, 2026, AtriCure, Inc. (ATRC) is the stronger overall head-to-head candidate over AXNX (AXNX) in the Tradestie Institutional Equity Comparison Engine, winning 9–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AXNX carries a Unified Composite Score of 52.1/100 (HOLD) at $0.83 (N/M Forward P/E, N/A operating margin), whereas ATRC carries 53.7/100 (HOLD) at $55.39 (122.1x Forward P/E, 2.9% operating margin). Technically, AXNX sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and ATRC sits in a Neutral phase (RSI 44.8, UNCLASSIFIED options structure).
ATRC leads the Growth & Scale pillar: AXNX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ATRC at +15.0% YoY revenue growth and +0.0% YoY earnings growth on $590M TTM revenue (76.7% gross margin, 2.9% operating margin). On trailing 12-month operating scale, AXNX generates N/A in USD-normalized revenue versus $590M for ATRC. In operating R&D and SG&A reinvestment, AXNX deploys N/A (0 90-day corporate R&D disclosures) versus 73.8% of Rev ($435M) (0 disclosures) for ATRC.
ATRC screens cheaper on headline valuation multiples. AXNX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ATRC trades at 122.1x Forward P/E, N/M Trailing P/E, 10.00x PEG, and 4.7x EV/Revenue (6.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AXNX (N/A ROE) versus ATRC (2.9% ROE) capital efficiency.
In options market volatility and institutional positioning, AXNX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk). By comparison, ATRC carries 44.5% implied volatility (74th %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 49% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.